Delivery Order SPE2DB22D2007-SPE2DB24FH8QX
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (adalimumab) medication. The contract has a firm fixed price of $3,647.40 and a performance period ending on April 9, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira (Adalimumab) medication. The contract has a ceiling value of $15,136.80 and a period of performance through December 12, 2023. It is a firm-fixed-price contract type, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (Adalimumab) medication, a specialty biologic drug used to treat various autoimmune conditions. The contract has a firm fixed price of $9,526.07 and a ceiling value of up to that amount. The delivery order is not set aside for any specific business type. Amerisourcebergen holds a larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Humira (adalimumab), a prescription medication used to treat various autoimmune conditions. The contract has a ceiling value of $43,341.96 and a period of performance through April 30, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,132.95, is for the delivery of Humira (adalimumab) injectable medication, a biologic drug used to treat various autoimmune conditions. The contract is a firm fixed-price, non-set-aside award with a performance period through May 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite...
- This is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the specialty medication Humira (adalimumab) at a firm fixed price of $3,002.48. The contract has an ultimate completion date of January 3, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Humira (adalimumab) medication. The contract has a ceiling value of $6,807.32 and is a firm-fixed price delivery order. It was awarded on August 27, 2024 with an ultimate completion date of August 28, 2024. The contract is not set aside for any special program. AmerisourceBergen, a major pharmaceutical distributor, will deliver the Humira medication to support the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $93,641.68, is for the supply of Humira (adalimumab) medication. It is a firm fixed-price delivery order contract with a completion date of February 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Humira (adalimumab) pharmaceutical medication. The contract has a ceiling value of $8,417.97 and a period of performance through October 16, 2024. This contract is not set aside for small businesses or other socioeconomic categories. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the pharmaceutical product Humira (adalimumab) with a ceiling value of $17,556.27 and a period of performance through April 15, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH8QXDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Humira (adalimumab) medication. The contract is a firm-fixed-price delivery order with a ceiling value of $10,143.07 and a period of performance through January 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 1/16/24 |